151 related articles for article (PubMed ID: 17646678)
1. Impact of Pycnogenol on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice.
Zibadi S; Yu Q; Rohdewald PJ; Larson DF; Watson RR
Cardiovasc Toxicol; 2007; 7(1):10-8. PubMed ID: 17646678
[TBL] [Abstract][Full Text] [Related]
2. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
[TBL] [Abstract][Full Text] [Related]
3. Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-β1 and MMPs Protein Expression.
Maneesai P; Bunbupha S; Potue P; Berkban T; Kukongviriyapan U; Kukongviriyapan V; Prachaney P; Pakdeechote P
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347737
[TBL] [Abstract][Full Text] [Related]
4. Carthamus Tinctorius L. extract attenuates cardiac remodeling in L-NAME-induced hypertensive rats by inhibiting the NADPH oxidase-mediated TGF-β1 and MMP-9 pathway.
Bunbupha S; Pakdeechote P; Maneesai P; Prachaney P; Boonprom P
Ann Anat; 2019 Mar; 222():120-128. PubMed ID: 30590121
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
[TBL] [Abstract][Full Text] [Related]
7. Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin deposition.
Hale SA; Weger L; Mandala M; Osol G
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1266-75. PubMed ID: 21856919
[TBL] [Abstract][Full Text] [Related]
8. Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
Jin L; Lin MQ; Piao ZH; Cho JY; Kim GR; Choi SY; Ryu Y; Sun S; Kee HJ; Jeong MH
J Hypertens; 2017 Jul; 35(7):1502-1512. PubMed ID: 28234674
[TBL] [Abstract][Full Text] [Related]
9. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574
[TBL] [Abstract][Full Text] [Related]
11. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
Hsu YH; Hsu BG; Chen HI
Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011
[TBL] [Abstract][Full Text] [Related]
12. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
Spinale FG; Coker ML; Bond BR; Zellner JL
Cardiovasc Res; 2000 May; 46(2):225-38. PubMed ID: 10773226
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
[TBL] [Abstract][Full Text] [Related]
14. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
Kazakov A; Hall R; Jagoda P; Bachelier K; Müller-Best P; Semenov A; Lammert F; Böhm M; Laufs U
Cardiovasc Res; 2013 Nov; 100(2):211-21. PubMed ID: 23863197
[TBL] [Abstract][Full Text] [Related]
16. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
[TBL] [Abstract][Full Text] [Related]
17. Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats.
Yang YL; Liu DD; Hsieh NK; Chen HI
Chin J Physiol; 2008 Jun; 51(3):186-95. PubMed ID: 18935914
[TBL] [Abstract][Full Text] [Related]
18. Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice.
Huet E; Gabison E; Vallee B; Mougenot N; Linguet G; Riou B; Jarosz C; Menashi S; Besse S
J Physiol Pharmacol; 2015 Jun; 66(3):355-66. PubMed ID: 26084217
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in mice.
Higuchi M; Yasuda O; Kawamoto H; Yotsui T; Baba Y; Ozaki T; Maeda N; Fukuo K; Rakugi H; Ogihara T
Hypertens Res; 2007 Jun; 30(6):563-71. PubMed ID: 17664861
[TBL] [Abstract][Full Text] [Related]
20. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
